No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

Intuition Robotics Names Dr. Michael Cantor, MD, JD, as the Company’s First Chief Medical Officer

Editor: What To Know

  • Michael Cantor will bring his expertise both as a geriatrician and as the former Chief Medical Officer of Bright Health Plan, a Medicare Advantage insurer, to aid the company’s efforts in leveraging ElliQ to bring care to older adults into their homes.
  • ElliQ’s unique and constant presence in the home, combined with the engagement levels the company has been seeing over the past few years, led the company to seek out a Chief Medical Officer to enhance their offering within the health space.
  • “I’m excited to be joining a company that brings care to the patient, rather than bringing the patient to the care, especially when it comes to older adults,”.

Intuition Robotics developer of empathetic digital companion™ technologies, announced today that Dr. Michael Cantor, MD has been named the company’s first Chief Medical Officer.

Dr. Michael Cantor will bring his expertise both as a geriatrician and as the former Chief Medical Officer of Bright Health Plan, a Medicare Advantage insurer, to aid the company’s efforts in leveraging ElliQ to bring care to older adults into their homes. The company recently announced their plan to extend to healthcare.

Before joining Intuition Robotics, Dr. Cantor was the Chief Medical Officer at Bright Health Plan, where he liaised with their network of doctors, clinics, and hospitals to provide the best healthcare possible. Before Bright, he was Chief Medical Officer for home healthcare company, CareCentrix, where he worked with payors and providers to create programs that improve quality and lower costs by allowing patients to heal and age at home. Prior to that, he was also the Chief Medical Officer for New England Quality Care Alliance and the New England Deputy Medical Director for UnitedHealthcare. Dr. Cantor trained in primary care internal medicine and geriatrics at Beth Israel Hospital/Harvard Medical School. He has degrees in law and medicine from the University of Illinois.

The Covid-19 pandemic has accelerated the demand for both in-home and virtual care, especially for older adults. ElliQ’s unique and constant presence in the home, combined with the engagement levels the company has been seeing over the past few years, led the company to seek out a Chief Medical Officer to enhance their offering within the health space. In his role as Chief Medical Officer, Dr. Cantor will assist in designing ElliQ’s capabilities, working alongside clinical teams to help them deliver better in-home care — liaising between the older adult ElliQ users and the healthcare ecosystem. Dr. Cantor will work closely with physicians to understand the best way to incorporate ElliQ into pathways of care, and how ElliQ can help them effectively improve the quality of their care.

“I’m excited to be joining a company that brings care to the patient, rather than bringing the patient to the care, especially when it comes to older adults,” says Dr. Michael Cantor, MD, JD, Chief Medical Officer of Intuition Robotics. “As a geriatrician, I appreciate how ElliQ allows older adults to age in place by creating stronger connections to the outside world. By adding additional health features to ElliQ, we can holistically support the older adult population by providing social companionship and enhancing relationships with their clinical team.”

“The pandemic showed the importance and challenges of delivering care at home to older adults. It became immediately clear that having ElliQ work together with care teams will dramatically improve the quality of care,” says Dor Skuler, CEO and Co-founder of Intuition Robotics. “We’re thrilled that someone with Dr. Cantor’s level of experience decided to join our company and help us extend ElliQ into healthcare. Dr. Cantor brings vast understanding in geriatric medicine that will no doubt prove crucial to our success.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."

Sedana Medical Completes Patient Recruitment for INSPiRE-ICU 1 Clinical Trial in the US

Peter Sackey further elaborated: "Once the 30-day follow-up of all patients is complete, we will enter into an intense phase of final monitoring, data cleaning and transfer to our statistician team for analysis. In parallel, the long-term outcomes at 3 and 6 months will be collected centrally by the Critical Illness, Brain Dysfunction, and Survivorship team at Vanderbilt Medical Center. With this parallel approach, we expect topline results in the autumn of this year and a swift regulatory submission in Q1, 2025".

Health / Lifestyle

Articles of Interest

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy